Equities

Newtopia Inc

NEWU:CVE

Newtopia Inc

Actions
Health CareHealth Care Providers
  • Price (CAD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded138.00k
  • 1 Year change-90.00%
  • Beta-1.2589
Data delayed at least 15 minutes, as of Sep 20 2024 19:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Newtopia Inc had revenues fall -12.38% from 11.17m to 9.78m, though the company grew net income from a loss of 7.70m to a smaller loss of 6.60m.
Gross margin54.01%
Net profit margin-78.19%
Operating margin-56.69%
Return on assets-197.12%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2023, Newtopia Inc increased its cash reserves by 11.96%, or 41.39k. Cash Flow from Financing totalled 2.31m or 23.65% of revenues. In addition the company used 2.27m for operations while cash used for investing totalled 2.55k.
Cash flow per share-0.0368
Price/Cash flow per share--
Book value per share-0.0636
Tangible book value per share-0.0636
More ▼

Balance sheet in CADView more

Newtopia Inc uses little or no debt in its capital structure.
Current ratio0.1267
Quick ratio0.1125
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.